Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 100-107

  Khan, Fozia ^a   Siddiqui, Asim A ^b  

^a Firoz Specialist Hospital   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

3 nitrotyrosine; Anti nitrotyrosine antibody; Osteoarthritis; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

3 NITROTYROSINE; 3 NITROTYROSINE ANTIBODY; ANTIBODY; IMMUNOGLOBULIN G; PROTEIN A; SEPHAROSE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NITRATION; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOARTHRITIS; SPECTRUM ANALYSIS; SYNOVIAL FLUID; TYROSINE;

EID: 33746482187     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.020     Document Type: Article

References (29)

1. Dandy D.J. Rheumatoid arthritis and other arthropathies. Essential orthopaedics and trauma (1989), Churchill Livingstone 289-296
2. Apley A.G., and Solomon L. Rheumatic disorders. System of orthopaedics and fractures. 6th edition (1982), ELBS 35-47
3. Dandy D.J. Osteoarthritis. Essential orthopaedics and trauma (1989), Churchill Livingstone 281-288
4. Sandhu J.K., Robertson S., Birnboim H.C., and Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 30 (2003) 1173-1181
5. Jacob L., Lety M.A., Bach J.F., and Louvard D. Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. Proc Natl Acad Sci 83 (1986) 6970-6974
6. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 45 (2003) 7-13
7. Yki-Jarvinen H., Bergholm M., and Leirisalo-Repo M. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis 62 (2003) 630-634
8. Greisberg J., Bliss M., and Terek R. The prevalence of nitric oxide in apoptotic chondrocytes of osteoarthritis. Osteoarthr Cartil 10 (2002) 207-211
9. Hashimoto S., Takahashi K., Amiel D., Coutts R.D., and Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 41 (1998) 1266-1274
10. Rolla G., Brussino L., Bertero M.T., et al. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J Rheumatol 24 (1997) 1066-1071
11. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci 101 (2004) 4003-4008
12. Ohmori H., Oka M., Nishikawa Y., et al. Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine. Immunol Lett 96 (2005) 47-54
13. Anderton S.M. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 16 (2004) 753-758
14. Oates J.C., Christensen E.F., Reilly C.M., Self S.E., and Gilkeson G.S. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians 111 (1999) 611-621
15. Klocke R., Mani A.R., Moore K.P., Blake D.R., and Mapp P.I. Inactivation of xanthine oxidoreductase is associated with increased joint swelling and nitrotyrosine formation in acute antigen-induced arthritis. Clin Exp Rheumatol 23 (2005) 345-350
16. Ohshima H., Friesen M., Brouet I., and Bartsch H. Nitrotyrosine as new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol 28 (1990) 647-652
17. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
18. Smith C.A., and Arnett Jr. F.C. Diagnosing rheumatoid arthritis: current criteria. Am Fam Phys 44 (1991) 863-870
19. Altman R.D. Criteria for classification of clinical osteoarthritis. J Rheumatol, Suppl 27 (1991) 10-12
20. Kaur H., and Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350 (1994) 9-12
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
22. Goding J.W. Use of staphylococcal protein A as an immunological reagent. J Immunol Methods 20 (1978) 241-253
23. Dixit K., Ahsan H., and Ali A. Polydeoxyribonucleotide C photoconjugated with lysine or arginine present unique epitopes for human anti-DNA autoantibodies. Hum Immunol 64 (2003) 880-886
24. Ali R., and Alam K. Evaluation of antibodies against oxygen free radical-modified DNA by ELISA. Methods Mol Biol 186 (2002) 171-181
25. Ahsan H., Ali A., and Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131 (2003) 398-404
26. Dixit K., and Ali R. Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 13 (2004) 95-100
27. Gonzalez-Gay M.A., Llorca1 J., Sanchez E., et al. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 43 (2004) 1182-1185
28. Morgan P.E., Sturgess A.D., and Davies M.J. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2069-2079
29. Levick J.R. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 24 (1981) 1550-1560